^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in combination with heparin sodium (Riker) 1000 units/L in dextrose 5%, sodium chloride 0.9%, and Ringer’s injection, lactated.

^d Tested in dextrose 5% in Ringer’s injection, dextrose 5% in Ringer’s injection, lactated, dextrose 5%, Ringer’s injection, lactated, and sodium chloride 0.9%.

^e Tested in both dextrose 5% and sodium chloride 0.9%.

^f Tested in bacteriostatic sodium chloride 0.9% preserved with benzyl alcohol 0.9%.

^g Tested in dextrose 5% in Ringer’s injection.

^h Tested in Ringer’s injection, lactated.

ⁱ Lyophilized formulation tested.

^j Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

^k Test performed using the formulation WITHOUT edetate disodium.

^l Tested in dextrose 5% in Ringer’s injection, lactated, dextrose 5%, Ringer’s injection, lactated, and sodium chloride 0.9%.

^m Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

ⁿ Quinupristin and dalfopristin components combined.

^o Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^p Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^q Test performed using the formulation WITH edetate disodium.

^r Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

^s As epinephrine base rather than the salt.

^t Diluent not specified.

^u Tested as the premixed infusion solution.

^v Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.